Scholars Central

Mini reviewPublished 29 Aug 2022

Polycystic Liver Disease Treatment: A Mini Review

Authors: Amy Omar

Journal of Nephrology & Therapeutics

Volume 12 · Issue 8 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Polycystic liver disease (PLD) can be autosomal dominant or isolated with no renal impairment. The natural course of liver cysts is for them to grow in size and number, resulting in progressive disease that can lead to extremely large and incapacitating hepatomegaly. Only symptomatic hepatomegaly (pain, inability to eat, weight loss, dyspnea) or cystic complications like infection or intracranial haemorrhage should be treated. PLD treatment thus encompasses a wide range of therapeutic options, from non-intervention to liver transplantation, including needle aspiration evacuation with sclerosant injection, laparoscopic fenestration, and fenestration by laparotomy combined with liver resection. The choice of treatment is determined by the symptomatology, intrahepatic extension of the lesions, and the patient's overall health.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nephrology & Therapeutics
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Amy Omar”